文献速递妇科产科

子宫内膜癌微创子宫切除术中使用宫内举宫器与生存关联的系统评价与荟萃分析

Survival Association of Intrauterine Manipulator Use During Minimally Invasive Hysterectomy for Endometrial Cancer: A Systematic Review and Meta-analysis.
PubMed 文献 · Obstet Gynecol · 2026-02-19

该系统评价与荟萃分析检索至2024年12月31日,纳入12项研究(10项回顾性研究、2项随机对照试验),共6,029例使用宫内举宫器和4,776例未使用者。未调整汇总分析显示,使用举宫器者无病生存率较低(HR 1.18,95%CI 1.01-1.38,P=.04),全因死亡HR 1.27(95%CI 0.99-1.62,P=.06)未达统计学显著。

要点

  • 未调整分析中,宫内举宫器使用与无病生存率降低相关(HR 1.18,95%CI 1.01-1.38,P=.04)。
  • 全因死亡风险HR 1.27(95%CI 0.99-1.62,P=.06),关联边缘且未达统计学显著。
  • 多数研究为回顾性且未充分调整预后因素,证据质量低至中等,结论需前瞻性试验验证。

核心结论

  • 微创子宫切除术中使用宫内举宫器可能与子宫内膜癌患者无病生存率降低相关,但与总生存的关联边缘且未达统计学显著。

研究设计与样本

  • 系统评价与荟萃分析,检索PubMed、Scopus、Web of Science和Cochrane Library至2024年12月31日。
  • 纳入12项比较研究(10项回顾性研究、2项随机对照试验),共6,029例使用宫内举宫器和4,776例未使用者。
  • 采用随机效应模型汇总数据,主要结局为无病生存和总生存。

主要发现

  • 未调整汇总分析中,使用宫内举宫器者无病生存率低于未使用者(9项研究,HR 1.18,95%CI 1.01-1.38,P=.04)。
  • 全因死亡HR为1.27(6项研究,95%CI 0.99-1.62,P=.06),未达统计学显著。
  • 仅4/12项研究(33.3%)调整了辅助治疗和肿瘤组织学等预后因素。
  • 7/12项研究(58.3%)存在中等偏倚风险,5项(41.6%)存在严重偏倚风险。

关键数值与推荐

  • 纳入比较研究包括前瞻性或回顾性研究及随机对照试验,评估子宫内膜癌微创子宫切除术中使用或不使用宫内举宫器的肿瘤学结局。
  • 排除结局数据不足、涉及开腹子宫切除术患者及非英文发表的研究。
  • 数据提取与合成遵循PRISMA指南,系统评价注册号PROSPERO CRD42023428140。

临床怎么用

  • 临床决策中应考虑宫内举宫器使用可能与无病生存降低相关的信号,但证据质量有限。
  • 需结合患者个体情况和现有证据等级,与患者充分沟通举宫器使用的潜在肿瘤学风险。
  • 期待未来前瞻性试验进一步明确宫内举宫器对生存结局的影响。

局限性

  • 多数纳入研究为回顾性,仅少数调整了辅助治疗和肿瘤组织学等预后因素。
  • 多数研究存在中等或严重偏倚风险,证据质量低至中等。
  • 未调整汇总分析可能受混杂因素影响,因果关联不能确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the association between intrauterine manipulator use and survival outcomes in patients undergoing minimally invasive hysterectomy for endometrial cancer because the oncologic effects of intrauterine manipulator use remain controversial. DATA SOURCES: A comprehensive systematic review of the literature published up to December 31, 2024, was conducted with the PubMed, Scopus, Web of Science, and Cochrane Library databases. METHODS OF STUDY SELECTION: Two independent investigators screened comparative studies, including prospective or retrospective studies and randomized controlled trials, examining oncologic outcomes in patients with endometrial cancer who underwent minimally invasive hysterectomy with or without an intrauterine manipulator. Studies with insufficient outcome data, including those involving patients who underwent open abdominal hysterectomy and those published in languages other than English, were excluded. TABULATION, INTEGRATION, AND RESULTS: Data extraction and synthesis were performed in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) guidelines. Random-effects analysis was used for data pooling. The primary outcomes were disease-free survival and overall survival. Confounding factors affecting prognosis and risk of bias were also evaluated. Between 2013 and 2024, 12 eligible studies, including 10 retrospective studies and two randomized controlled trials, enrolled 6,029 patients who underwent minimally invasive hysterectomy with an intrauterine manipulator and 4,776 patients without one. In the unadjusted pooled analysis, disease-free survival was lower in patients who underwent surgery with an intrauterine manipulator than in those without (nine studies, hazard ratio 1.18, 95% CI, 1.01-1.38, P =.04). Albeit statistically nonsignificant, the hazard ratio for all-cause mortality comparing intrauterine manipulator use with nonuse was 1.27 (six studies, 95% CI, 0.99-1.62, P =.06). Only a limited number of studies (4 of 12 studies, 33.3%) examined survival outcomes after adjustment for factors such as adjuvant treatment and tumor histology. Most studies (7 of 12, 58.3%) had a moderate risk of bias, and five (41.6%) had a serious risk of bias. CONCLUSION: This meta-analysis suggests that intrauterine manipulator use during minimally invasive hysterectomy may be associated with decreased disease-free survival in patients with endometrial cancer; however, the association with overall survival is marginal and did not reach statistical significance. Considering that most studies included in this meta-analysis were retrospective, did not adjust for prognostic factors such as postoperative treatment, and were of low to moderate quality, the associations found in this study warrant further investigation in future prospective trials. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42023428140.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Nagase Y, Matsuzaki S, Yoshida H, et al. Survival Association of Intrauterine Manipulator Use During Minimally Invasive Hysterectomy for Endometrial Cancer: A Systematic Review and Meta-analysis. Obstet Gynecol. 2026. PMID: 41712940. doi:10.1097/AOG.0000000000006195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。